Leeds Scientific Wins Approval in France
Savvy French consumers and distributors alike have praised Sculptisse for having powerful results that safely and effectively eliminates wrinkles faster than most wrinkle creams on the market.
Las Vegas, NV, December 01, 2010 --(PR.com)-- According to Mintel, a leading market intelligence gathering firm in Europe, nearly two thirds (62%) of French women are using anti-wrinkle products. Their research also shows that French women led the way in anti-aging purchases in 2009, with retail sales exceeding €2.2 billion. Furthermore, the combined market value is expected to grow even further to exceed €6.5 billion by 2013.
“We’ve already had great sales records in the United States so naturally we expected positive results in France," says Michael Sweaney, CEO manufacturer of Sculptisse, a new anti-aging cream that helps people avoid costly surgery.
Savvy French consumers and distributors alike have praised the new product for having powerful results that safely and effectively eliminates wrinkles faster than most wrinkle creams on the market. The results are so impressive their distributor has posted “one take” French video infomercials on the company’s website, so people can see the immediate results for themselves in real time.
About Leeds Scientific: Based out of Las Vegas, NV, Leeds Scientific (http://leedsscientific.net) intrinsically administrates fully tested materials to allow them to enthusiastically re-engineer worldwide manufactured anti-aging brands. They are a manufacturer who is aLways on the cutting edge of anti-aging product development. They accomplish this with their commitment to only producing high quality effective products, bottling and labeling them, then shipping them to distributors worldwide.
Forward-Looking Statements:
This news release includes comments that may be deemed forward-looking within the meaning of the safe harbor provisions of the U.S. Federal Securities Laws. These include, among other things, statements about expectations of future events or transactions, sales of products or performance. Forward-looking statements are subject to risks and uncertainties that may cause the company's results to differ materially from expectations. These risks include the company's ability to execute its business plan, having necessary financing in time to meet contractual obligations and support the business activity, and other such risks as the company may identify and discuss from time to time, including those risks disclosed in the company's current and future filings with the Securities and Exchange Commission. Accordingly, there is no certainty that the company's plans will be achieved.
###
“We’ve already had great sales records in the United States so naturally we expected positive results in France," says Michael Sweaney, CEO manufacturer of Sculptisse, a new anti-aging cream that helps people avoid costly surgery.
Savvy French consumers and distributors alike have praised the new product for having powerful results that safely and effectively eliminates wrinkles faster than most wrinkle creams on the market. The results are so impressive their distributor has posted “one take” French video infomercials on the company’s website, so people can see the immediate results for themselves in real time.
About Leeds Scientific: Based out of Las Vegas, NV, Leeds Scientific (http://leedsscientific.net) intrinsically administrates fully tested materials to allow them to enthusiastically re-engineer worldwide manufactured anti-aging brands. They are a manufacturer who is aLways on the cutting edge of anti-aging product development. They accomplish this with their commitment to only producing high quality effective products, bottling and labeling them, then shipping them to distributors worldwide.
Forward-Looking Statements:
This news release includes comments that may be deemed forward-looking within the meaning of the safe harbor provisions of the U.S. Federal Securities Laws. These include, among other things, statements about expectations of future events or transactions, sales of products or performance. Forward-looking statements are subject to risks and uncertainties that may cause the company's results to differ materially from expectations. These risks include the company's ability to execute its business plan, having necessary financing in time to meet contractual obligations and support the business activity, and other such risks as the company may identify and discuss from time to time, including those risks disclosed in the company's current and future filings with the Securities and Exchange Commission. Accordingly, there is no certainty that the company's plans will be achieved.
###
Contact
Leeds Scientific
Brian Gallagher
(877) 340-4039
leedsscientific.net
Brian Gallagher
(877) 340-4039
leedsscientific.net
Contact
Categories